Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Stephanie, Stookey"'
Autor:
Angela Alme, Stephanie Stookey, Michael Rubenstein, Charles J. Bieberich, Angelo M. De Marzo, Rebecca Keener, Sagar Bajpai, Charles G. Drake, Arya Ashok, Jessica Hicks, Qizhi Zheng, Srinivasan Yegnasubramanian, Levent Trabzonlu
Publikováno v:
The Prostate. 79:732-745
Background Elevated expression of the proinflammatory cytokine interleukin 1β (IL-1β) has been observed in expressed prostatic secretions of patients with chronic prostatitis/chronic pelvic pain syndrome, and genetic polymorphisms associated with t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::abbfc94a30d10c566ed9a05463403abc
https://doi.org/10.1002/pros.23784
https://doi.org/10.1002/pros.23784
Autor:
Arya, Ashok, Rebecca, Keener, Michael, Rubenstein, Stephanie, Stookey, Sagar, Bajpai, Jessica, Hicks, Angela K, Alme, Charles G, Drake, Qizhi, Zheng, Levent, Trabzonlu, Srinivasan, Yegnasubramanian, Angelo M, De Marzo, Charles J, Bieberich
Publikováno v:
The Prostate. 79(7)
Elevated expression of the proinflammatory cytokine interleukin 1β (IL-1β) has been observed in expressed prostatic secretions of patients with chronic prostatitis/chronic pelvic pain syndrome, and genetic polymorphisms associated with the IL1B gen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bc6c98fe1471add5f7ffbaeda0868b95
https://pubmed.ncbi.nlm.nih.gov/30900284
https://pubmed.ncbi.nlm.nih.gov/30900284
Autor:
Tyler A. Cunningham, Stephanie Stookey, Maryalice Stetler Stevenson, Ira Pastan, Margaret C. Cam, Fabian Müller, Parthav Jailwala, Chin-Hsien Tai, Sandra Burkett, Alan S. Wayne
Publikováno v:
Proceedings of the National Academy of Sciences. 115
Moxetumomab pasudotox (Moxe) is a chimeric protein composed of an anti-CD22 Fv fused to a portion of Pseudomonas exotoxin A and kills CD22-expressing leukemia cells. It is very active in hairy-cell leukemia, but many children with relapsed/refractory
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d9f06a589cc4c2c6a3ce527359802aa0
https://doi.org/10.1073/pnas.1714512115
https://doi.org/10.1073/pnas.1714512115
Autor:
Stephanie Stookey, Ira Pastan, Fabian Mueller, Alan S. Wayne, Tyler Cunningham, Chin-Hsien Tai
Publikováno v:
Blood. 128:2810-2810
Background: Moxetumomab pasudotox (Moxe) is a recombinant immunotoxin that targets CD22. Moxe showed high clinical activity in a phase II trial against hairy cell leukemia (Kreitman et al, 2012) and a phase III trial has recently completed enrollment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d3948897cb6a804a4c36595b36cece2
https://doi.org/10.1182/blood.v128.22.2810.2810
https://doi.org/10.1182/blood.v128.22.2810.2810